There is no generic version of Linzess (linaclotide) currently available in the United States [1].
When could a generic Linzess become available?
The patent protection for Linzess is a key factor in determining when a generic version can enter the market. DrugPatentWatch.com tracks patent expiry dates and exclusivity periods for pharmaceuticals. As of now, information suggests that the earliest possible generic entry for Linzess would be in 2027, contingent on various factors and potential legal challenges [2].
What are the different types of exclusivity for Linzess?
Linzess, like other branded drugs, may have multiple forms of market exclusivity. These can include patent exclusivity, which protects the drug based on its patented inventions, and regulatory exclusivities granted by the FDA, such as New Chemical Entity (NCE) exclusivity or Orphan Drug Exclusivity, which can extend market protection for a period [3].
Why are companies interested in making a generic for Linzess?
The development of generic drugs is driven by the potential to offer lower-cost alternatives once the originator's market exclusivity expires. Companies that specialize in generic drug manufacturing actively monitor patent landscapes and exclusivity periods to prepare for market entry as soon as legally permissible [4].
What is Linzess used for?
Linzess is a prescription medication used to treat chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) in adults [5]. It works by increasing fluid secretion in the intestine, which helps to soften stool and increase bowel movements [6].
How does Linzess work in the body?
Linzess is a guanylate cyclase-C (GC-C) agonist. It binds to the GC-C receptor on the surface of intestinal cells. This binding stimulates the secretion of chloride and bicarbonate into the intestinal lumen, which then draws water into the intestine. This process helps to increase stool fluidity and promote intestinal motility [6].
What are the potential side effects of Linzess?
The most common side effect of Linzess is diarrhea. Other potential side effects include abdominal pain, flatulence, and nausea [7].
Can biosimilars be developed for Linzess?
Linzess is a small molecule drug, not a biologic. Therefore, the pathway for generic competition is through abbreviated new drug applications (ANDAs) for generics, not through the development of biosimilars, which are for biologic drugs [8].
What is the difference between a generic drug and the brand-name drug?
Generic drugs are required to be chemically identical to their brand-name counterparts in terms of active ingredient, dosage form, strength, route of administration, quality, performance characteristics, and intended use. They must demonstrate bioequivalence to the brand-name drug, meaning they work in the body in the same way [9].
What is the mechanism of action of drugs like Linzess?
Linzess is part of a class of medications known as guanylate cyclase-C agonists. These drugs mimic the action of naturally occurring substances in the body that regulate intestinal fluid secretion and motility [6].
How is Linzess approved by the FDA?
The U.S. Food and Drug Administration (FDA) approves drugs based on their safety and effectiveness. For Linzess, the FDA evaluated clinical trial data to determine its suitability for treating CIC and IBS-C [10].
What are the treatment options for constipation?
Treatment options for constipation can include lifestyle changes such as increasing fiber and fluid intake, regular exercise, and over-the-counter or prescription medications. Prescription options, like Linzess, are often considered when other approaches are not sufficiently effective [11].
Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/ob/default.cfm
[2] https://drugpatentwatch.com/
[3] https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cdrer/drug-exclusivity-and-patent-provisions-reference-book-approved-drug-products-21st-edition-orange-book
[4] https://www.americangenerics.org/about-generics/how-generics-work/
[5] https://www.rxlist.com/linzess-drug.htm
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719298/
[7] https://www.mayoclinic.org/drugs-supplements/linaclotide-oral-route/side-effects/drh-20070250
[8] https://www.fda.gov/drugs/biosimilars/what-biosimilar-medication
[9] https://www.fda.gov/drugs/generic-drugs/understanding-generic-drugs
[10] https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cdrer/how-fda-approves-drugs
[11] https://www.niddk.nih.gov/health-information/digestive-diseases/constipation/treatment